Affimed N.V. Stock price
Is Affimed N.V. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?
As a Free StocksGuide user, you can view scores for all 9,127 stocks worldwide.
Key metrics
Affimed N.V. Stock Analysis
Analyst Opinions
10 Analysts have issued a Affimed N.V. forecast:
Analyst Opinions
10 Analysts have issued a Affimed N.V. forecast:
Don't miss a Thing! We will send you all news about Affimed N.V. directly to your mailbox free of charge.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Company Profile
Affimed NV engages in discovering and developing of targeted cancer immunotherapies. Its pipelines include Innate Cell Engagers and T Cell Engagers. The company was founded in 2000 and is headquartered in Heidelberg, Germany.
| Head office | Netherlands |
| CEO | Mr. Leland |
| Employees | 76 |
| Founded | 2000 |
| Website | www.affimed.com |


